258 related articles for article (PubMed ID: 28334634)
21. Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals.
Qu X; Zhang Y; Li Y; Hu X; Xu Y; Xu L; Hou K; Sada K; Liu Y
FEBS Lett; 2009 Jul; 583(13):2255-62. PubMed ID: 19508871
[TBL] [Abstract][Full Text] [Related]
22. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
23. CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling.
Kang JM; Park S; Kim SJ; Hong HY; Jeong J; Kim HS; Kim SJ
Oncogene; 2012 Dec; 31(50):5123-31. PubMed ID: 22310290
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
25. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Zhang Y; Liu J; Qu J; Hu X; Zhang F; Zheng H; Qu X; Liu Y
Eur J Cancer; 2012 Nov; 48(17):3288-99. PubMed ID: 22456178
[TBL] [Abstract][Full Text] [Related]
26. C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
Li W; Xu L; Che X; Li H; Zhang Y; Song N; Wen T; Hou K; Yang Y; Zhou L; Xin X; Xu L; Zeng X; Shi S; Liu Y; Qu X; Teng Y
BMC Cancer; 2018 May; 18(1):507. PubMed ID: 29720121
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals.
Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ
Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263
[TBL] [Abstract][Full Text] [Related]
28. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin ligase Cbl-b and inhibitory Cblin peptides.
Nikawa T; Ishidoh K
Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140495. PubMed ID: 32663526
[TBL] [Abstract][Full Text] [Related]
30. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
[TBL] [Abstract][Full Text] [Related]
31. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
[TBL] [Abstract][Full Text] [Related]
32. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
33. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
34. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.
Wang Y; Chen L; Wu Z; Wang M; Jin F; Wang N; Hu X; Liu Z; Zhang CY; Zen K; Chen J; Liang H; Zhang Y; Chen X
BMC Cancer; 2016 Nov; 16(1):826. PubMed ID: 27842510
[TBL] [Abstract][Full Text] [Related]
35. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
36. The protein content of an adaptor protein, STAP-2 is controlled by E3 ubiquitin ligase Cbl.
Sekine Y; Yamamoto C; Ikeda O; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(2):187-92. PubMed ID: 19401194
[TBL] [Abstract][Full Text] [Related]
37. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.
Yang SW; Ping YF; Jiang YX; Luo X; Zhang X; Bian XW; Yu PW
Oncotarget; 2016 Jun; 7(26):39279-39292. PubMed ID: 27276686
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.
Shi R; Wang C; Fu N; Liu L; Zhu D; Wei Z; Zhang H; Xing J; Wang Y
Oncol Rep; 2019 May; 41(5):3015-3026. PubMed ID: 30896886
[TBL] [Abstract][Full Text] [Related]
39. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
[TBL] [Abstract][Full Text] [Related]
40. Enigma prevents Cbl-c-mediated ubiquitination and degradation of RETMEN2A.
Kales SC; Nau MM; Merchant AS; Lipkowitz S
PLoS One; 2014; 9(1):e87116. PubMed ID: 24466333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]